| muscle tissue development | GO:0060537 | 308 | 0.722 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.650 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.599 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.593 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.562 | |
| regulation of cell migration | GO:0030334 | 219 | 0.504 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.451 | |
| angiogenesis | GO:0001525 | 201 | 0.404 | |
| fat cell differentiation | GO:0045444 | 160 | 0.378 | Mouse |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.375 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.361 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.359 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.343 | |
| muscle cell development | GO:0055001 | 133 | 0.332 | |
| myotube differentiation | GO:0014902 | 105 | 0.325 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.320 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.300 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.284 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.278 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.269 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.266 | |
| telencephalon development | GO:0021537 | 186 | 0.258 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.253 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.243 | |
| embryonic placenta development | GO:0001892 | 98 | 0.235 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.234 | |
| cytokine production | GO:0001816 | 319 | 0.230 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.225 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.224 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.223 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.223 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.222 | |
| stem cell maintenance | GO:0019827 | 130 | 0.218 | |
| organ growth | GO:0035265 | 117 | 0.216 | |
| female sex differentiation | GO:0046660 | 84 | 0.214 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.214 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.210 | |
| multicellular organism growth | GO:0035264 | 161 | 0.207 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.206 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.205 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.201 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.199 | |
| regulation of cell motility | GO:2000145 | 236 | 0.196 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.193 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.191 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.189 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.189 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.188 | |
| immune effector process | GO:0002252 | 321 | 0.186 | Mouse |
| regionalization | GO:0003002 | 337 | 0.185 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.185 | |
| placenta development | GO:0001890 | 140 | 0.184 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.184 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.183 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.181 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.180 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.178 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.173 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.172 | |
| mapk cascade | GO:0000165 | 281 | 0.172 | |
| respiratory system development | GO:0060541 | 190 | 0.172 | |
| gtp metabolic process | GO:0046039 | 144 | 0.169 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.169 | |
| cardiac muscle tissue growth | GO:0055017 | 37 | 0.166 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.164 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.162 | |
| oxidation reduction process | GO:0055114 | 342 | 0.160 | Mouse |
| labyrinthine layer blood vessel development | GO:0060716 | 21 | 0.159 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.157 | |
| hindbrain development | GO:0030902 | 128 | 0.157 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.157 | |
| heart growth | GO:0060419 | 45 | 0.157 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.156 | |
| amine metabolic process | GO:0009308 | 45 | 0.153 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.152 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.152 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.148 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.146 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.146 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.145 | |
| striated muscle cell development | GO:0055002 | 125 | 0.145 | |
| neural tube closure | GO:0001843 | 90 | 0.145 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.143 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.143 | Mouse |
| forebrain development | GO:0030900 | 302 | 0.143 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.142 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.141 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.140 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.140 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.140 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.140 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.140 | |
| heart morphogenesis | GO:0003007 | 178 | 0.140 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.139 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.138 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.136 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.135 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.132 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.132 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.132 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.131 | |
| negative regulation of axon guidance | GO:1902668 | 8 | 0.130 | |
| tissue migration | GO:0090130 | 68 | 0.129 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.128 | |
| spermatogenesis | GO:0007283 | 284 | 0.127 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.126 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.126 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.125 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.124 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.124 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.124 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.123 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.122 | |
| placenta blood vessel development | GO:0060674 | 31 | 0.121 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.121 | |
| neuron projection extension | GO:1990138 | 64 | 0.121 | |
| adult behavior | GO:0030534 | 135 | 0.120 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.120 | |
| positive regulation of growth | GO:0045927 | 104 | 0.118 | |
| ear morphogenesis | GO:0042471 | 118 | 0.118 | |
| cardiac muscle cell proliferation | GO:0060038 | 31 | 0.117 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.117 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.116 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.115 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.115 | |
| blood circulation | GO:0008015 | 195 | 0.114 | |
| cation homeostasis | GO:0055080 | 212 | 0.113 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.113 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.113 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.111 | |
| branching involved in salivary gland morphogenesis | GO:0060445 | 26 | 0.111 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.110 | |
| compound eye development | GO:0048749 | 1 | 0.110 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.110 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.108 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.108 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.108 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.107 | |
| cell fate commitment | GO:0045165 | 210 | 0.107 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 22 | 0.105 | |
| gtp catabolic process | GO:0006184 | 143 | 0.105 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.105 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.105 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.103 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.103 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.102 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.101 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.101 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.101 | |
| male sex differentiation | GO:0046661 | 109 | 0.100 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.100 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.099 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.099 | |
| tube closure | GO:0060606 | 91 | 0.097 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.097 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.097 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.096 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.095 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.095 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.095 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.094 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.094 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.093 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.093 | |
| somitogenesis | GO:0001756 | 69 | 0.092 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.092 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.091 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.091 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.091 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.091 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.091 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.091 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.090 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.090 | |
| circulatory system process | GO:0003013 | 197 | 0.089 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.089 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.089 | |
| regulation of ion transport | GO:0043269 | 215 | 0.089 | |
| lung development | GO:0030324 | 164 | 0.089 | |
| transmembrane transport | GO:0055085 | 412 | 0.089 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.088 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.087 | |
| regulation of heart growth | GO:0060420 | 31 | 0.086 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.086 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.086 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.085 | |
| cerebral cortex development | GO:0021987 | 86 | 0.085 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.085 | |
| axon guidance | GO:0007411 | 141 | 0.084 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.084 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.084 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.084 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.083 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.082 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.082 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.082 | |
| developmental induction | GO:0031128 | 34 | 0.081 | |
| gonad development | GO:0008406 | 141 | 0.081 | |
| blood coagulation | GO:0007596 | 76 | 0.081 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.080 | |
| positive regulation of jun kinase activity | GO:0043507 | 30 | 0.080 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.080 | |
| appendage development | GO:0048736 | 166 | 0.080 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.080 | |
| membrane organization | GO:0061024 | 245 | 0.079 | |
| embryonic placenta morphogenesis | GO:0060669 | 25 | 0.078 | |
| cell adhesion | GO:0007155 | 329 | 0.078 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.078 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.077 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.077 | |
| stem cell differentiation | GO:0048863 | 268 | 0.077 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.076 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.076 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.076 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.076 | |
| male gonad development | GO:0008584 | 88 | 0.075 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.075 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.074 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.074 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.074 | |
| labyrinthine layer morphogenesis | GO:0060713 | 21 | 0.074 | |
| positive regulation of ureteric bud formation | GO:0072107 | 3 | 0.074 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.073 | |
| fertilization | GO:0009566 | 127 | 0.073 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.072 | |
| myoblast differentiation | GO:0045445 | 52 | 0.072 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.072 | |
| glandular epithelial cell differentiation | GO:0002067 | 38 | 0.072 | |
| muscle system process | GO:0003012 | 141 | 0.072 | Mouse |
| epithelial cell development | GO:0002064 | 159 | 0.072 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.071 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.071 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.070 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.070 | |
| negative regulation of hormone biosynthetic process | GO:0032353 | 4 | 0.070 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.070 | |
| positive regulation of heart growth | GO:0060421 | 18 | 0.069 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.069 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.069 | |
| maintenance of cell number | GO:0098727 | 3 | 0.069 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.069 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.068 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.068 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.068 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.068 | |
| female gonad development | GO:0008585 | 71 | 0.067 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.067 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.066 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.066 | |
| limb development | GO:0060173 | 166 | 0.066 | |
| endocrine system development | GO:0035270 | 98 | 0.065 | |
| mesoderm formation | GO:0001707 | 62 | 0.064 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.064 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.064 | |
| regulation of secretion | GO:0051046 | 274 | 0.063 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.063 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.063 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.063 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.063 | |
| membrane depolarization | GO:0051899 | 64 | 0.063 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.063 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.063 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.062 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.062 | |
| renal tubule development | GO:0061326 | 87 | 0.062 | |
| regulation of myoblast differentiation | GO:0045661 | 29 | 0.061 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.061 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.061 | |
| cardiac epithelial to mesenchymal transition | GO:0060317 | 18 | 0.061 | |
| epithelial cell migration | GO:0010631 | 63 | 0.061 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.061 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.061 | |
| morphogenesis of an epithelial bud | GO:0060572 | 18 | 0.061 | |
| muscle fiber development | GO:0048747 | 76 | 0.061 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.060 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.060 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.060 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.060 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.060 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.060 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.060 | |
| acetylcholine secretion neurotransmission | GO:0014055 | 2 | 0.060 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.059 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.058 | |
| bone morphogenesis | GO:0060349 | 78 | 0.058 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.058 | |
| stem cell proliferation | GO:0072089 | 117 | 0.058 | |
| respiratory tube development | GO:0030323 | 167 | 0.058 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.057 | |
| myotube cell development | GO:0014904 | 60 | 0.057 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.057 | |
| limb morphogenesis | GO:0035108 | 149 | 0.057 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.057 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.057 | |
| regulation of cell size | GO:0008361 | 72 | 0.056 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.056 | |
| mesenchyme development | GO:0060485 | 152 | 0.056 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.056 | |
| inflammatory response | GO:0006954 | 244 | 0.056 | Mouse |
| stem cell development | GO:0048864 | 219 | 0.055 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.055 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.055 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.055 | |
| artery development | GO:0060840 | 53 | 0.055 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.055 | |
| cell division | GO:0051301 | 120 | 0.055 | |
| germ cell development | GO:0007281 | 185 | 0.054 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.054 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.054 | |
| hematopoietic stem cell proliferation | GO:0071425 | 13 | 0.054 | |
| organelle fission | GO:0048285 | 170 | 0.054 | |
| cell recognition | GO:0008037 | 83 | 0.054 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.053 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.053 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.052 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.052 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.052 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.052 | |
| jnk cascade | GO:0007254 | 72 | 0.052 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.052 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.052 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.052 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.051 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.051 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.051 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.051 | |
| cartilage development | GO:0051216 | 140 | 0.051 | |
| somatotropin secreting cell development | GO:0060133 | 2 | 0.051 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.051 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.051 | |
| sensory perception | GO:0007600 | 245 | 0.051 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.051 | |
| sensory perception of chemical stimulus | GO:0007606 | 51 | 0.051 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.051 | |
| cellular homeostasis | GO:0019725 | 240 | 0.050 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.050 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 34 | 0.050 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.049 | |
| bone mineralization | GO:0030282 | 54 | 0.049 | |
| kidney epithelium development | GO:0072073 | 121 | 0.049 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.048 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.048 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.048 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.048 | |
| male gamete generation | GO:0048232 | 285 | 0.048 | |
| nuclear division | GO:0000280 | 158 | 0.048 | |
| hindbrain formation | GO:0021576 | 1 | 0.048 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.048 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.048 | |
| kidney development | GO:0001822 | 213 | 0.048 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.047 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.047 | |
| regulation of jun kinase activity | GO:0043506 | 40 | 0.047 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.047 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.047 | |
| cell differentiation in hindbrain | GO:0021533 | 24 | 0.047 | |
| negative regulation of alcohol biosynthetic process | GO:1902931 | 4 | 0.046 | |
| specification of organ identity | GO:0010092 | 30 | 0.046 | |
| forebrain neuron development | GO:0021884 | 30 | 0.046 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.046 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.046 | Mouse |
| learning or memory | GO:0007611 | 148 | 0.046 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.046 | |
| regulation of organ growth | GO:0046620 | 61 | 0.046 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.046 | |
| organ induction | GO:0001759 | 21 | 0.046 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.046 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.046 | |
| nephron epithelium development | GO:0072009 | 92 | 0.046 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.045 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.045 | |
| glycosylation | GO:0070085 | 62 | 0.045 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.045 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.045 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.045 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.045 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.045 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.045 | |
| regulation of axon extension | GO:0030516 | 43 | 0.045 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.045 | |
| nephron tubule development | GO:0072080 | 84 | 0.045 | |
| regulation of endothelial cell migration | GO:0010594 | 22 | 0.044 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.044 | |
| epithelium migration | GO:0090132 | 63 | 0.044 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.044 | |
| locomotory behavior | GO:0007626 | 195 | 0.044 | |
| syncytium formation | GO:0006949 | 43 | 0.044 | |
| regulation of cell division | GO:0051302 | 76 | 0.044 | |
| cellular response to parathyroid hormone stimulus | GO:0071374 | 2 | 0.044 | |
| transdifferentiation | GO:0060290 | 1 | 0.044 | |
| ear development | GO:0043583 | 200 | 0.043 | |
| regulation of cell growth | GO:0001558 | 91 | 0.043 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.043 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.043 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.043 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.043 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.043 | |
| epidermis development | GO:0008544 | 187 | 0.043 | |
| rhythmic process | GO:0048511 | 174 | 0.043 | |
| endothelial cell migration | GO:0043542 | 44 | 0.043 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.042 | |
| nephron development | GO:0072006 | 109 | 0.042 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.042 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.042 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.042 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.042 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.042 | |
| extracellular structure organization | GO:0043062 | 148 | 0.042 | |
| cellular polysaccharide metabolic process | GO:0044264 | 38 | 0.042 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.042 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.042 | |
| synapse assembly | GO:0007416 | 56 | 0.042 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.042 | |
| ureteric bud development | GO:0001657 | 94 | 0.042 | |
| chemotaxis | GO:0006935 | 247 | 0.042 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.042 | |
| defense response to other organism | GO:0098542 | 197 | 0.042 | Mouse |
| response to growth factor | GO:0070848 | 198 | 0.042 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.042 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.041 | |
| synapse organization | GO:0050808 | 125 | 0.041 | |
| tube formation | GO:0035148 | 140 | 0.041 | |
| ossification | GO:0001503 | 216 | 0.041 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.041 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.041 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.041 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.040 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.040 | |
| sensory perception of taste | GO:0050909 | 18 | 0.040 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.040 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.040 | |
| leukocyte migration | GO:0050900 | 124 | 0.040 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.040 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.040 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.040 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.040 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.040 | Mouse |
| cation transport | GO:0006812 | 399 | 0.040 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.039 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.039 | |
| interleukin 8 production | GO:0032637 | 4 | 0.039 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.039 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.039 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.039 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.039 | |
| chromatin organization | GO:0006325 | 206 | 0.039 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.038 | |
| neuron projection extension involved in neuron projection guidance | GO:1902284 | 14 | 0.038 | |
| neural tube formation | GO:0001841 | 108 | 0.038 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.038 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.038 | |
| spemann organizer formation | GO:0060061 | 2 | 0.038 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.038 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.038 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.038 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.038 | |
| epithelial tube formation | GO:0072175 | 130 | 0.038 | |
| regulation of ossification | GO:0030278 | 112 | 0.037 | |
| positive regulation of smoothened signaling pathway | GO:0045880 | 23 | 0.037 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.037 | |
| protein maturation | GO:0051604 | 176 | 0.037 | |
| mitral valve development | GO:0003174 | 4 | 0.036 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.036 | |
| regulation of protein processing | GO:0070613 | 96 | 0.036 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.036 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.036 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.036 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.036 | |
| regulation of protein binding | GO:0043393 | 60 | 0.036 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.036 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.036 | |
| lung induction | GO:0060492 | 3 | 0.036 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.035 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.035 | |
| heart contraction | GO:0060047 | 93 | 0.035 | |
| b cell differentiation | GO:0030183 | 78 | 0.035 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.035 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.035 | Mouse |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.035 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.035 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.035 | |
| hexose metabolic process | GO:0019318 | 98 | 0.035 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.035 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.035 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 25 | 0.035 | |
| pallium development | GO:0021543 | 120 | 0.035 | |
| insulin like growth factor receptor signaling pathway | GO:0048009 | 21 | 0.035 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.035 | |
| b cell activation | GO:0042113 | 161 | 0.034 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.034 | |
